Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 9/20 | 0.53 |
| ▸ | PIM1 | P11309 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.50 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.50 |
| ▸ | PRNP | P04156 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | DRD2 | P14416 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.50 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.50 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18890496 | 1.00 | KDM1A (0.53) | KDM1APIM1SIGMAR1SLC22A1PRNP | |
| SCHEMBL30622707 | 0.90 | KDM1A (0.59) | KDM1APIM1SIGMAR1SLC22A1PRNP | |
| SCHEMBL18550498 | 0.90 | KDM1A (0.59) | KDM1APIM1SIGMAR1SLC22A1PRNP | |
| SCHEMBL30834583 | 0.86 | KDM1A (0.49) | KDM1APIM1SIGMAR1SLC22A1PRNP | |
| SCHEMBL8859048 | 0.82 | FPR2 (0.56) | KDM1APIM1SIGMAR1SLC22A1PRNP | |
| SCHEMBL19897039 | 0.79 | DRD2 (0.49) | KDM1APIM1TP53DRD2HTR2A | |
| SCHEMBL19897085 | 0.79 | SNCA (0.50) | KDM1ATP53CYP1A2CHRM2HTR1A | |
| SCHEMBL29935425 | 0.78 | KDM4E (0.40) | TP53FPR2LMNAKDM4EALDH1A1 | |
| SCHEMBL19067492 | 0.78 | MAPT (0.74) | KDM1ASIGMAR1SLC22A1PRNPTP53 | |
| SCHEMBL19067438 | 0.78 | MAPT (0.74) | KDM1ASIGMAR1SLC22A1PRNPTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024085749-A1 | A NON-AQUEOUS REDOX FLOW BATTERY | TECHNISCHE UNIVERSITEIT EINDHOVEN (NL) | 2024-04-25 | — | — | WO | claimed |
| US-20250389690-A1 | MAN-TO-MACHINE INTERFACE TOWARD AUTOMATED ELECTROCHEMISTRY EXPERIMENTS | UNIV KENTUCKY RES FOUND (US) | 2025-12-25 | — | — | US | disclosed |
| WO-2025202358-A1 | USE OF KETAZINE-BASED REDOX SPECIES IN ELECTROLYTES FOR REDOX FLOW BATTERIES | Forschungszentrum Jülich GmbH (DE) | 2025-10-02 | — | — | WO | disclosed |
| CN-119948664-A | High-energy solid-state battery and method for manufacturing same | 瓦特里股份有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-12199282-B2 | Halogenated battery comprising a greenhouse gas | WATTRII Inc. (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240339644-A1 | Symmetric Redox Molecules Using Synergistic Electron Directing Pairs | ExxonMobil Technology and Engineering Company (US) | 2024-10-10 | — | — | US | disclosed |
| US-20240282989-A1 | PHENOTHIAZINE DERIVATIVES AND REDOX-FLOW BATTERIES | UNIV KENTUCKY RES FOUND (US) | 2024-08-22 | — | — | US | disclosed |
| EP-4374443-A1 | SELF-CHARGING ELECTROCHEMICAL CELLS | Wattrii, Inc. (US) | 2024-05-29 | — | — | EP | disclosed |
| WO-2024085749-A1 | A NON-AQUEOUS REDOX FLOW BATTERY | TECHNISCHE UNIVERSITEIT EINDHOVEN (NL) | 2024-04-25 | — | — | WO | disclosed |
| CN-117751475-A | Self-charging electrochemical cell | 瓦特里股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| WO-2023004361-A1 | SELF-CHARGING ELECTROCHEMICAL CELLS | WATTRII, Inc. (US) | 2023-01-26 | — | — | WO | disclosed |
| WO-2022060750-A1 | HALOGENATED BATTERY COMPRISING A GREENHOUSE GAS | KIM JANGWOO (US) | 2022-03-24 | — | — | WO | disclosed |
| US-20220093922-A1 | HALOGENATED BATTERY COMPRISING A GREENHOUSE GAS | WATTRII Inc. (US) | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250389690-A1 | MAN-TO-MACHINE INTERFACE TOWARD AUTOMATED ELECTROCHEMISTRY EXPERIMENTS | CA1, SET, ACHE | KDM1A 404/4885PIM1 465/4885SIGMAR1 2940/4885 |
| US-20240282989-A1 | PHENOTHIAZINE DERIVATIVES AND REDOX-FLOW BATTERIES | GPX4, NDUFV2, NDUFV1 | KDM1A 3883/4885PIM1 1793/4885SIGMAR1 998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.